【レポートの概要（一部）】
1. Report Overview
1.1 The Molecular Diagnostics Market Overview
1.2 Molecular Diagnostics Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Reports
1.10 About Visiongain
2. Introduction to Molecular Diagnostics
2.1 What are In Vitro Diagnostic (IVD) Tests?
2.2 Classifying In Vitro Diagnostics
2.2.1 FDA Classifications
2.2.2 IVD Classification in Australia
2.2.3 The EC (European Commission) Classification
2.3 IVD Submarkets
2.3.1 Clinical Chemistry
2.3.2 Immunochemistry
2.3.3 Point-of-care Testing (Including Self-monitoring Blood Glucose Tests)
2.3.4 Molecular Diagnostics
2.3.4.1 Infectious Disease Testing
2.3.4.2 Oncology Testing
2.3.4.3 Blood Screening
2.3.4.4 Genetic Testing
2.3.4.5 Tissue Typing (HLA Testing)
2.3.5 Clinical Microbiology
2.3.6 Haematology/ Haemostasis
2.4 Regulation of the IVD and MDx Market
2.4.1 FDA and CLIA Regulation of IVD and MDx Tests
2.4.1.1 Regulation of IVD/MDx Tests in the EU: The EC (European Commission) Classification
2.4.2 Top Ten Challenges in Regulation for In-Vitro Diagnostics
2.4.2.1 Challenges in Regulations of MDx tests
2.5 Device Excise Tax: A Threat to the Diagnostics Manufacturers
3. The Molecular Diagnostics Segment Within the In Vitro Diagnostics Market, 2014-2024
3.1 Molecular Diagnostics in the IVD Market, 2013
3.2 Sales Forecast for the Global IVD Market 2014-2024
3.3 Molecular Diagnostics Gaining Greater Share of the IVD Market
4. The Molecular Diagnostics Market by Sectors, 2014-2024
4.1 The Molecular Diagnostic Market by Sectors, 2013
4.2 The Molecular Diagnostic Market by Sectors 2014-2024
4.2.1 Market Shares of the Molecular Diagnostics Sectors 2014-2024
4.3 The Infectious Disease Testing Market 2014-2024
4.3.1 Breakdown of the MDx Infectious Disease Testing Market by Disease, 2013
4.3.1.1 HPV Testing
4.3.1.2 CT/NT
4.3.1.3 HIV
4.3.1.4 Hepatitis C (HCV)
4.3.1.5 MRSA/ C. diff
4.4 The Oncology Testing Market, 2014-2024
4.4.1 Targeted Therapies: A Major Driver of the Oncology Testing Market
4.4.2 Molecular Diagnostics: Currently Concentrated on a Few Cancer Indications
4.4.2.1 Breast Cancer
4.4.2.2 Prostate Cancer
4.4.2.2.1 Pipeline Biomarker
4.4.2.2.1.1 TMPRSS2-ERG (OriGene)
4.4.2.2.1.2 PTEN
4.4.2.3 Colorectal Cancer
4.5 The Blood Screening Market 2014-2024
4.5.1 Grifols’ Acquisition of Novartis’s Blood Screening Unit
4.5.2 Leading Blood Screening Test Products
4.5.2.1 Cobas s 201 System (Roche Molecular)
4.5.2.2 Procleix Assays (Grifols)
4.6 The Genetic Testing Market 2014-2024
4.6.1 Genetic Testing by Clinical Impact Area
4.6.2 Genetic Testing: Potentially Many More Disease Indications
4.6.3 Cystic fibrosis
4.6.4 Factor V Leiden and Factor II Thrombophilia
4.6.5 Inflammatory diseases
4.6.5.1 Alzheimer’s Disease (AD)
4.6.5.2 Rheumatoid Arthritis
4.6.5.2.1 Vectra®DA (Crescendo Bioscience)
4.6.5.2.2 Quest Diagnostics: Biomarker Study
4.6.5.3 Rare Diseases
4.7 The Tissue Typing (HLA) Market 2014-2024
4.7.1 Tissue Typing: Next Generation Sequencing
5. The Leading Molecular Diagnostics National Markets, 2014-2024
5.1 Regional Breakdown of the Global MDx Market, 2013
5.2 The Global MDx Market Forecast 2014-2024
5.3 The Regional Market Shares of the MDx Market, 2014-2024
5.4 The US MDx Market 2013: Representing More than Half of the Global Market
5.4.1 The US MDx Market Forecast 2014-2024
5.4.1.1 United States: Diagnostic Reimbursement
5.5 The European MDx Markets Forecast, 2014-2024
5.5.1 Changes in the Shares of the Leading European Markets, 2014-2024
5.5.2 The German MDx Market Forecast 2014-2024
5.5.3 The French MDx Market Forecast 2014-2024
5.5.4 The Italian MDx Market Forecast 2014-2024
5.5.5 The Spanish MDx Market Forecast 2014-2024
5.5.6 The UK MDx Market Forecast 2014-2024
5.5.7 The Other European MDx Markets Forecast 2014-2024
5.6 The Japanese MDx Market Forecast 2014-2024
5.7 The Chinese MDx Market Forecast 2014-2024
5.7.1 China: Increasing Cancer Burden
5.8 The Brazilian MDx Market Forecast 2014-2024
5.9 The Russian MDx Market Forecast 2014-2024
5.10 The Indian MDx Market Forecast 2014-2024
5.10.1 India: Expansion of Healthcare Provisions
5.11 The South Korean MDx Market Forecast 2014-2024
5.12 The Mexican MDx Market Forecast 2014-2024
5.13 The Rest of the World Market Forecast 2014-2024
6. The Leading Companies in the Molecular Diagnostics Market, 2014-2024
6.1 Roche Diagnostics
6.1.1 Roche: Global Presence
6.1.2 Roche Diagnostics, 2014-2024
6.1.3 Roche Diagnostics Business Performance within the IVD Market, 2013
6.1.3.1 Molecular Diagnostics Sales Performance, 2013
6.1.3.2 Molecular Diagnostic Sales by Region, 2013
6.1.4 Roche Diagnostics: MDx Product Launches and Indication Expansion, 2014
6.1.4.1 Roche Diagnostics: Product Launch Plans, 2014
6.1.4.2 Roche: Recent M&A Activity and Strategic Partnerships
6.2 Hologic Gen-Probe
6.2.1 Hologic Recent Sales Performance by Business Segment, 2013
6.2.2 Hologic Molecular Diagnostics: Product Portfolio
6.2.3 Product Pipeline: Infectious Disease Focus, but Prostate Cancer Diagnostics Shows Promise
6.2.4 Changes in Molecular Diagnostic Operations Structuring
6.3 Qiagen
6.3.1 Sales and Recent Performance Analysis, 2013
6.3.2 Qiagen Sales by Region, 2013
6.3.3 Qiagen Sales by Segment, 2013
6.3.4 Qiagen: Molecular Diagnostics
6.3.5 Molecular Diagnostics: Product Expansion
6.3.5.1 QIASymphony
6.3.5.2 QuantiFERON-TB Gold: Expansion into China
6.3.5.3 Personalised Healthcare: Collaborative Efforts
6.3.5.4 Bioinformatics: Software Company Acquisitions
6.4 Becton, Dickinson & Company
6.4.1 Sales and Financial Performance, 2013
6.4.2 Sales and Financial Performance by Region, 2013
6.4.3 Becton Dickinson Diagnostics Sales and Financial Performance, 2012-2013
6.4.4 BD Diagnostics: Product Portfolio
6.4.5 BD Diagnostics: Mergers and Acquisitions
6.5 BioMérieux
6.5.1 Sales and Recent Performance Analysis, 2010-2013
6.5.2 Sales by Region, 2013
6.5.3 Sales by Technology, 2013
6.5.4 Molecular Diagnostics: Product Portfolio
6.5.5 Companion Diagnostics: Collaboration with GSK
6.5.6 Mergers and Acquisitions
6.5.7 bioTheranostics: Subsidiary for Oncology Diagnostics
6.6 Cepheid
6.6.1 Sales and Recent Performance Analysis, 2010-2013
6.6.2 Sales by Industry Segment, 2012-2013
6.6.3 Sales by Region, 2012-2013
6.6.4 Cepheid: Product Line
6.6.5 Cepheid: Business strategy
6.7 Agilent (Dako)
6.7.1 Sales and Recent Performance Analysis, 2013
6.7.2 Sales Performance by Business Segment, 2013
6.7.3 Agilent: Strong Player in Next Generation Sequencing
7. Qualitative Analysis of the MDx Market, 2014-2024
7.1 MDx market: Drivers and Restraints
7.2 SWOT Analysis of the MDx Market, 2014-2024
7.3 Strength
7.3.1 Patient Demographics
7.3.2 Increased Awareness
7.3.3 High Growth in Oncology Molecular Diagnostics
7.3.4 Increasing Laboratory Test Menus
7.3.5 Personalised Medicine: Optimising Treatment Outcomes
7.4 Weaknesses
7.4.1 Lack of Clear Regulatory Guidelines for Molecular Diagnostics
7.4.2 Reimbursement Challenges for Molecular Diagnostic Companies
7.4.2.1 Consolidation of Healthcare Systems Increases Pricing Pressure
7.4.2.2 Reimbursement Uncertainty Discourages Capital Investment
7.4.3 MDx: An Expensive, but Undervalued Diagnostic Tool
7.5 Opportunities
7.5.1 Next-generation Sequencing
7.5.2 Emerging Markets
7.5.3 The Emergence of New Microorganisms
7.6 Threats
7.6.1 US Medical Device Excise Tax
7.6.2 Gene Patents: Controversial Ruling
7.7 Porter’s Five Forces Analysis of the MDx Market
7.7.1 Rivalry Among Competitors [High]
7.7.2 Threat of New Entrants [Medium]
7.7.3 Power of Suppliers [Medium]
7.7.4 Power of Buyers [High]
7.7.5 Threat of Substitutes [High]
8. Expert Opinions
8.1 Mike Nugent, Worldwide Market Segment Leader BD MAX, BD Diagnostics
8.1.1 Becton Dickinson’s Leadership in Infectious Disease Molecular Diagnostics
8.1.2 BD MAX System: Becton Diagnostics Leading Product
8.1.3 The Changing Landscape of the MDx Industry
8.1.4 Cost: A Deterrent of MDx Use
9. Conclusions
9.1 The Molecular Diagnostics Market: Growing Market Share
9.2 Molecular Diagnostics: Oncology Testing Market Growth
9.3 Commercial Drivers of the Molecular Diagnostics Market
9.4 Commercial Restraints of the Molecular Diagnostics Market
9.5 Emerging Markets
9.6 Concluding Remarks
【レポート販売概要】
■ タイトル：世界の分子診断市場：感染症検査、癌検査、血液検査、遺伝子検査■ 英文：The Molecular Diagnostics (MDx) Market Forecast 2014-2024 : Opportunities for Leading Companies
■ 発行日：2014年10月
■ 調査会社：visiongain
■ 商品コード：VGAIN4120202
■ 調査対象地域：グローバル
- 世界におけるビジネス旅行者向けの空港小売市場動向（2014-2015）Summary “Global Business Travelers' Airport Retail Trends, 2014-2015” is a new report by Conlumino that globally analyzes prevailing trends in airport retailing and explores how business dynamics are set to change in 2014-2015. This highlights the key drivers and barriers influencing customer opinion and purchasing pattern, and identifies preferred product categories, frequently used payment modes …
- Oil and Natural Gas Corporation Limited：石油・ガスバリューチェーン分析レポート2013Oil and Natural Gas Corporation Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Oil and Natural Gas Corporation Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Oil and Natural Gas Corporation Limited”. The report provides key information relating to oil and gas assets of the company along wi …
- 玩具・ゲームの世界市場2017-2021ABSTRACTAbout Toys and Games Toys and games are used for the amusement and entertainment of children. Activity toys such as building sets, dolls, puzzles such as jigsaw puzzles, and card games help children enhance their mental agility and develop coordination and manual skills. The increasing consumer demand for branded toys and games, the growing willingness of parents to spend more on such prod …
- 帯状疱疹ワクチン（Herpes Zoster vaccine）の世界市場機会分析Varicella-zoster virus is a ubiquitous human alphaherpesvirus, which after infection in childhood causes a relatively mild self-limiting illness. However, if the virus becomes reactivated later on in life it can cause a painful rash (shingles), often leading to postherpetic neuralgia (PHN). PHN has a significant economic burden because patients require systemic anti-viral therapy and pain manageme …
- 急性背部痛（Acute Back Pain）：グローバル臨床試験レビュー（2014年上半期）Acute Back Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Acute Back Pain Global Clinical Trials Review, H1, 2014" provides data on the Acute Back Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Back Pain. It includes an overview of the trial numbers and their recruitment status as …
- 世界のアイデンティティ及びアクセス管理市場動向（2012-2016）TechNavio's analysts forecast the Global Identity and Access Management market to grow at a CAGR of 13.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing government regulatory norms. The Global Identity and Access Management market has also been witnessing an increased number of merger and acquisitions. However, the increasing complexit …
- ボールベアリング（玉軸受）の世界市場2016-2020About Ball Bearing Bearings are machine elements used to reduce energy loss caused by friction in the rotary motion parts of a wide range of equipment and machinery. There are various types of bearings like ball bearings, roller bearings, and plain bearings. Technological advances and the growing need for energy efficiency have resulted in continuous improvement in bearing designs. Technavio’s ana …
- 建築・建設用アルミニウムの世界市場：アルミニウム押出製品、アルミニウムRFP、アルミニウム鋳物、アルミニウム粉末About the Aluminum Market for Building and Construction Sector The aluminum industry value chain consists of both upstream and downstream sectors. Operations of upstream sectors include mining (extraction of bauxite) and refining (bauxite to alumina). The commonly used process for extracting bauxite is the Bayer process. The downstream operations involve casting, smelting, and fabricating the refi …
- 世界の空調（HVAC）装置市場動向（2012-2016）TechNavio's analysts forecast the Global Heating, Ventilation, and Air Conditioning (HVAC) Equipment market to grow at a CAGR of 5.88 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of construction activities. The market has also been witnessing the evolution of monitoring systems and intelligent technology. However, complying w …
- スマートフォン市場：新しいユーザーパラダイム及び行動（Smartphones: New user paradigms and behaviors）The Smartphone market is currently the fastest-growing segment and it will continue to outpace the overall handset market for the foreseeable future. User friendly platform and evolving user behavior pattern are responsible for its exponential growth. In the past few years Smartphone sales have grown exponentially. In 2011, 472 million Smartphone were sold worldwide. This is expected to rise to 1 …
- 2014年戦略提言：ヨーロッパの呼吸器病診断検査市場Complete report $8,300. DataPack (test volumes, sales forecasts, supplier shares) $5,400.This new 335-page report from Venture Planning Group provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this ReportThis report pr …
- 電動バイク向けリチウムイオン電池の世界市場About Li-ion Battery for E-bikes An e-bike is integrated with a small electric motor and rechargeable batteries that assist the rider in pedaling. Equipped with the power assist, an e-bike facilitates pedaling with minimal effort, even when riding uphill or against the wind. E-bikes are environment friendly and their increased use can really create a measurable impact on the reduction of carbon em …
- 医療機器委託製造の世界市場予測2016-2026What can be expected from the Medical Device Contract Manufacturing Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects. Our 234-page report provides 152 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study …
- 世界のヘテロジニアス・モバイル処理及びコンピューティング市場：プロセッサ、グラフィック処理ユニット、DSP、接続ソリューション等Heterogeneous mobile processing (HMP) and computing defines the architecture in which processors, DSPs (Digital Signal Processor), GPUs (Graphic Processing Units), connectivity solutions (Wi-Fi, Bluetooth), and software are being integrated to accelerate the performance and computational abilities of System on Chip (SoC). These entire components work simultaneously to improve the performance and s …
- ソーシャルゲーム市場参入と成功戦略分析2013（Social Gaming Market Entry and Success Strategy Analysis 2013）The significant rise of social networks has created a springboard for the social gaming segment of the entertainment industry. Gaming is becoming increasingly compelling thanks to various enhancements such as the addition of socially playable and sharable features within games, which have gradually become common characteristics. While generally a lucrative segment, the industry has its own challen …
